VERACYTE, INC. current report, 19 February 2022

Business Context and Reporting Period

This Form 8-K filing by Veracyte, Inc. (VCYT) reports on events occurring on February 19, 2022, and effective February 22, 2022. The filing details significant changes in executive leadership within the finance department, specifically the appointment of a new Chief Accounting Officer and the departure of the incumbent.

Key Financial Metrics

This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on personnel changes and associated compensation arrangements.

Material Changes

  • Appointment: Jonathan Wygant was appointed Vice President and Chief Accounting Officer, effective February 22, 2022.
  • Transition: Beverly Jane Alley was appointed Vice President, Accounting, effective February 22, 2022. She will serve as the Principal Accounting Officer until March 1, 2022, when Mr. Wygant assumes the role.
  • Departure: Ms. Alley agreed to depart the Company on June 30, 2022.

Compensation, Risks, and Unusual Items

Compensation Arrangements

Jonathan Wygant (New CAAO):

  • Base Salary: $350,000 annually.
  • Discretionary Bonus: Up to 35% of base salary.
  • Stock Options: 24,000 shares vesting 25% after one year, then monthly over 36 months.
  • Restricted Stock Units (RSUs): 12,000 shares vesting 25% on March 2, 2023, then quarterly over 12 quarters.

Beverly Jane Alley (Departing Officer):

  • Severance: Three months' salary upon departure on June 30, 2022.
  • Benefits: Continuation of COBRA coverage.
  • Condition: Receipt of severance is contingent upon a standard release of claims.

Risks and Contingencies

The filing notes that the summaries of the Offer Letter and Letter Agreement are subject to the full terms of those documents, which will be filed as exhibits to the Form 10-Q for the quarter ending March 31, 2022. No other material risks or contingencies were disclosed in this report.

Investor Verification Checklist

  • Verify the full text of the Offer Letter and Letter Agreement when filed as exhibits to the Q1 2022 Form 10-Q.
  • Confirm the exact vesting schedules and performance conditions for Mr. Wygant's equity awards.
  • Monitor the transition of the Principal Accounting Officer role to ensure continuity in financial reporting.
  • Review the Q1 2022 10-Q for any impact of these personnel changes on internal controls or financial operations.